Misleading associations between cholesterol and vascular outcomes in dialysis patients: the need for randomized trials.

Misleading associations between cholesterol and vascular outcomes in dialysis patients: the need for randomized trials.

Higher cholesterol is strongly associated with an increased risk of coronary heart disease (CHD) in nonrenal populations, so the lack of a clear positive association between total cholesterol and mortality among dialysis patients is unexpected. This review of prospective studies of the association b...

書目詳細資料
Main Authors:	Baigent, C, Landray, M, Wheeler, D
格式:	Journal article
語言:	English
出版:	2007

相似書籍

Impact of prior myocardial infarction and vascular disease on the risk of subsequent cardiac events among 68 730 patients commencing dialysis.
由: Landray, M, et al.
出版: (2002)

Statin therapy in kidney disease populations: potential benefits beyond lipid lowering and the need for clinical trials.
由: Baigent, C, et al.
出版: (2004)

Evidence for the prevention and treatment of stroke in dialysis patients
由: Herrington, W, et al.
出版: (2014)

Benefits of lowering cholesterol in chronic kidney disease Reply
由: Baigent, C, et al.
出版: (2011)

Effect on non-vascular outcomes of lowering LDL cholesterol in patients with chronic kidney disease: Results from the study of heart and renal protection
由: Reith, C, et al.
出版: (2017)

Should we reduce blood cholesterol to prevent cardiovascular disease among patients with chronic renal failure?
由: Baigent, C, et al.
出版: (2000)

Misleading graphs in context: Less misleading than expected
由: Jannetje E. P. Driessen, et al.
出版: (2022-01-01)

Misleading graphs in context: Less misleading than expected.
由: Jannetje E P Driessen, et al.
出版: (2022-01-01)

Effect on non-vascular outcomes of lowering LDL cholesterol in patients with chronic kidney disease: results from the Study of Heart and Renal Protection
由: C. Reith, et al.
出版: (2017-05-01)

Beautiful small: Misleading large randomized controlled trials? The example of colloids for volume resuscitation
由: Christian J Wiedermann, et al.
出版: (2015-01-01)

Misleading analyses.
由: Peto, R
出版: (1978)

Misleading Reference
由: Peter Harremoës
出版: (2010-05-01)

The misleading pulse
由: Bhushan Sudhakar Wankhade, et al.
出版: (2013-07-01)

The need for large-scale randomized evidence.
由: Baigent, C
出版: (1997)

SERUM LIPIDS DO NOT PREDICT CARDIOVASCULAR OUTCOMES IN CHRONIC KIDNEY DISEASE PATIENTS
由: Landray, M, et al.
出版: (2005)

Study of Heart and Renal Protection (SHARP): Randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease
由: Baigent, C, et al.
出版: (2010)

Pragmatic trials - need for ADAPTABLE design
由: Baigent, C
出版: (2021)

Two-year survival among patients with chronic-kidney disease not on dialysis: The chronic renal impairment in Birmingham (CRIB) study.
由: Nuttall, S, et al.
出版: (2003)

Relationships between monocyte count to high-density lipoprotein cholesterol ratio and cardiovascular outcomes in patients commencing dialysis
由: Dongryul Kim, et al.
出版: (2021-11-01)

Elective conversion to sirolimus vs. continued tacrolimus in kidney transplantation (the 3c study): Results of a randomized trial
由: Haynes, R, et al.
出版: (2017)

Reclaiming mendelian randomization from the deluge of papers and misleading findings
由: Stefan Stender, et al.
出版: (2024-09-01)

A Misleading Trismus
由: A. Galzerano, et al.
出版: (2011-01-01)

Polypharmacy: Misleading, but manageable
由: Reamer L Bushardt, et al.
出版: (2008-06-01)

An Ambiguous and Misleading Description
由: Shuai Qiang, PhD, et al.
出版: (2020-06-01)

REMINISCENCE CAN BE MISLEADING
由: N.D. Orpen
出版: (2012-02-01)

The effect of lowering LDL cholesterol on vascular access patency: post hoc analysis of the Study of Heart and Renal Protection.
由: Herrington, W, et al.
出版: (2014)

Results of a Large Randomized Controlled Trial of Alemtuzumab-Versus Basiliximab-Based Induction Therapy in Kidney Transplantation
由: Haynes, R, et al.
出版: (2014)

Results of a Large Randomized Controlled Trial of Alemtuzumab-Versus Basiliximab-Based Induction Therapy in Kidney Transplantation
由: Haynes, R, et al.
出版: (2014)

Cross-sectional analysis of abnormalities of mineral homeostasis, vitamin D and parathyroid hormone in a cohort of pre-dialysis patients. The chronic renal impairment in Birmingham (CRIB) study.
由: Zehnder, D, et al.
出版: (2007)

Lowering LDL cholesterol reduces cardiovascular risk independently of presence of inflammation
由: Storey, B, et al.
出版: (2017)

Randomized clinical trials--removing unnecessary obstacles.
由: Reith, C, et al.
出版: (2013)

Cholesterol and lipids
由: Baigent, C, et al.
出版: (2008)

Cholesterol and total mortality: need for larger trials.
由: Collins, R, et al.
出版: (1992)

The Effects of Statins Unrelated to Cholesterol level on Clinical Outcome of Continuous Ambulatory Peritoneal Dialysis Patients
由: Sug kyun Shin, et al.
出版: (2012-06-01)

Randomized Evaluation of the Effects of Anacetrapib through Lipid-modification (REVEAL)—A large-scale, randomized, placebo-controlled trial of the clinical effects of anacetrapib among people with established vascular disease: Trial design, recruitment, and baseline characteristics
由: Landray, M, et al.
出版: (2017)

Sex-specific exposures and sex-combined outcomes in two-sample Mendelian randomization may mislead the causal inference
由: Zhenqian Wang, et al.
出版: (2022-10-01)

Similar Symptomatology Can Mislead; A Temporal Epilepsy Case Reverting From Vascular Surgery
由: Eda KILIÇ ÇOBAN, et al.
出版: (2021-09-01)

Cancer survival figures are misleading.
由: Oke, J
出版: (2014)

Misleading subgroup analyses in GISSI
由: Peto, R
出版: (1990)

“RATING”: IS THIS WORD MOBILIZING OR MISLEADING?
由: Ivan E. Zadorozhnyuk
出版: (2016-12-01)